|
|
Article: Sucampo Pharmaceuticals Strengthens Its Board of Directors.
- Article from:
- Biotech Week
- Article date:
- September 10, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) announced that Gayle Dolecek, P.D., M.P.H., has been appointed to its Board of Directors. Dr. Dolecek is currently Sucampo's Senior Vice President of Research and Development (see also Sucampo Pharmaceuticals, Inc.).
"We are pleased to welcome Dr. Gayle Dolecek to Sucampo's Board of Directors," said Ryuji Ueno, M.D., Ph.D., Ph.D., Sucampo Pharmaceuticals' Chairman and Chief Executive Officer. "Gayle has worked with Sucampo since its founding, first as a consultant and now as head of research and development. He guided the development of Sucampo's regulatory strategy, ensuring compliance with FDA's complex requirements, ...